Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff Sonnenfeld and Steven Tian.

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting with activist investor Starboard Value, Pfizer's former CEO and CFO publicly changed their tune after being threatened with litigation by Pfizer,

CEO Albert Bourla is expected to meet with activist investor Starboard Value next week after the activist accumulated a $1 billion stake in the pharma giant. Bourla and at least one other director are set to hold discussions with Starboard next week,